An Official Website of the United States Government
Company Information:
Name:
MYOMICS, INC.
Address:
MYOMICS, INC.
148 West River Street
PROVIDENCE, RI 02904 2615
148 West River Street
PROVIDENCE, RI 02904 2615
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
SBIR Phase I: Physiologic High Throughput Screening of Bioengineered Tissues
Award Year / Program / Phase:
2006 / SBIR / Phase I
Agency:
NSF
Principal Investigator:
Herman Vandenburgh, Dr
Award Amount:
$99,991.00
Abstract:
The Small Business Innovation Research (SBIR) Phase I project will develop an innovative high-throughput/ high content drug screening platform utilizing three-dimensional human skeletal muscle tissue constructs which mimic in vivo skeletal muscle to quantify muscle force generation. The proposed… More
Electro-Mechanical Micro-Post Array to Detect In Vitro Muscle Contraction
Award Year / Program / Phase:
2006 / STTR / Phase I
Agency:
HHS
Research Institution:
MIRIAM HOSPITAL
Abstract:
DESCRIPTION (provided by applicant): Myomics? technology to be developed in this Phase 1 project is based upon an in vitro skeletal muscle tissue force measurement technique for high throughput screening (HTS) of compounds to attenuate muscle weakness. The technology, termed Patterned… More
High Content Screening for Muscular Dystrophy
Award Year / Program / Phase:
2007 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Herman H. Vandenburgh
Award Amount:
$99,912.00
Abstract:
DESCRIPTION (provided by applicant): Myomics' drug screening technology to be developed in this Phase 1 SBIR project for Duchene muscular dystrophy (DMD) is based upon an in vitro skeletal muscle tissue force measurement technique for high content screenin
g (HCS) of compounds to attenuate muscle… More
SBIR Phase II: Physiologic High Throughput Screening of Bioengineered Tissues
Award Year / Program / Phase:
2007 / SBIR / Phase II
Agency:
NSF
Principal Investigator:
Herman D. Vandenburgh, PhD
Award Amount:
$499,956.00
Abstract:
This Small Business Innovation Research (SBIR) Phase II research develops an innovative high-throughput/high content drug screening platform that utilizes three-dimensional human skeletal muscle tissue constructs that mimic in vivo skeletal muscle to quantify muscle force generation. Significant… More
High Content Drug Screening with Cardiac Tissue
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Herman H. Vandenburgh
Award Amount:
$98,136.00
Abstract:
DESCRIPTION (provided by applicant): Myomics, Inc. has developed High Content Drug Screening (HCS) technology for in vitro testing of compounds which alter contractile forces generated by miniaturized tissue engineered organs (Myo-Force Assay SystemTM, MFA
STM). Myomics' 3-D tissue/force sensor… More
High Content Screening for Muscular Dystrophy
Award Year / Program / Phase:
2009 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Herman H. Vandenburgh
Award Amount:
$991,988.00
Abstract:
DESCRIPTION (provided by applicant): Duchenne Muscular Dystrophic (DMD) is a fatal genetic disease affecting tens of thousands of boys in the U.S. There is currently no cure for the disease and few drugs are available to slow the progressive loss in skele
tal muscle strength. Glucocorticoids such… More